Skip to main content
. 2021 Feb 12;8(3):677–686. doi: 10.1002/acn3.51311

Table 1.

Clinical characteristics between anti‐MDA5 and antibody‐negative DM groups.

Criterion Anti‐MDA5 Antibody negative DM P‐value
Female, n (%) 9 (82) 7 (70) 0.635
Age of onset, years 52.1 ± 8.7 53.1 ± 14.5 0.847
Disease duration, months 4.1 ± 3.1 5.9 ± 4.6 0.296
Skin ulcers, n (%) 8 (73) 0 0.001 *
Interstitial lung disease, n (%) 11 (100) 2 (20) <0.001 *
MMT8 scores 71.3 ± 6.1 63.2 ± 8.4 0.020 *
CK level, IU/L 185.2 ± 209.1 2149.1 ± 2677.4 0.036 *

Bold indicates the data that had significant difference after pairwise comparison.

MMT, manual muscle test; CK, creatine kinase.

*

P < 0.05.